Zimmer Biomet Holdings Inc. is a global leader in musculoskeletal healthcare, dedicated to alleviating pain and improving the quality of life for patients worldwide. The company's mission revolves around innovation in orthopedic and dental solutions, focusing on advanced technologies and surgical products. Zimmer Biomet's strategy emphasizes strategic partnerships, research and development, and a commitment to enhancing patient outcomes through comprehensive solutions. With a diverse portfolio of products and a strong presence in the global market, Zimmer Biomet operates with the goal of transforming the healthcare landscape and providing exceptional value to healthcare providers and patients alike.

ZIMMER BIOMET HOLDINGS INC

Zimmer Biomet Holdings, Inc. is making significant strides in the orthopedic market with its recent FDA approval for the Oxford® Cementless Partial Knee implant, which marks it as the only FDA-approved cementless partial knee replacement in the United States. This approval allows for improved surgical efficiency and enhanced implant longevity,...

Zimmer Biomet Receives FDA Approval for First Cementless Partial Knee Implant, Set for Nationwide Launch in 2025

Zimmer Biomet is set to revolutionize orthopedic surgery with the FDA's approval of the Oxford® Cementless Partial Knee implant, the first of its kind in the U.S. Can this innovative solution, boasting a 94.1% survival rate, reshape the future of joint replacements?